Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aclarion, Inc. stock logo
ACONW
Aclarion
$0.02
+15.3%
$0.03
$0.02
$0.23
N/AN/A20,998 shs2,095 shs
DHACW
Digital Health Acquisition
$0.03
-14.4%
$0.04
$0.01
$0.40
N/AN/A71,147 shs487 shs
LifeMD, Inc. stock logo
LFMDP
LifeMD
$23.65
+0.6%
$23.69
$18.50
$24.34
N/AN/A2,302 shs13,999 shs
The Oncology Institute, Inc. stock logo
TOIIW
Oncology Institute
$0.04
-6.4%
$0.05
$0.03
$0.27
N/AN/A17,212 shs3,099 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aclarion, Inc. stock logo
ACONW
Aclarion
-6.69%+0.40%-5.28%-38.48%-30.08%
DHACW
Digital Health Acquisition
0.00%0.00%+10.13%-11.84%-0.42%
LifeMD, Inc. stock logo
LFMDP
LifeMD
-0.43%0.00%-1.05%-1.67%-2.77%
The Oncology Institute, Inc. stock logo
TOIIW
Oncology Institute
+10.00%-12.82%-25.20%-18.16%-27.10%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aclarion, Inc. stock logo
ACONW
Aclarion
$0.02
+15.3%
$0.03
$0.02
$0.23
N/AN/A20,998 shs2,095 shs
DHACW
Digital Health Acquisition
$0.03
-14.4%
$0.04
$0.01
$0.40
N/AN/A71,147 shs487 shs
LifeMD, Inc. stock logo
LFMDP
LifeMD
$23.65
+0.6%
$23.69
$18.50
$24.34
N/AN/A2,302 shs13,999 shs
The Oncology Institute, Inc. stock logo
TOIIW
Oncology Institute
$0.04
-6.4%
$0.05
$0.03
$0.27
N/AN/A17,212 shs3,099 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aclarion, Inc. stock logo
ACONW
Aclarion
-6.69%+0.40%-5.28%-38.48%-30.08%
DHACW
Digital Health Acquisition
0.00%0.00%+10.13%-11.84%-0.42%
LifeMD, Inc. stock logo
LFMDP
LifeMD
-0.43%0.00%-1.05%-1.67%-2.77%
The Oncology Institute, Inc. stock logo
TOIIW
Oncology Institute
+10.00%-12.82%-25.20%-18.16%-27.10%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aclarion, Inc. stock logo
ACONW
Aclarion
0.00
N/AN/AN/A
DHACW
Digital Health Acquisition
0.00
N/AN/AN/A
LifeMD, Inc. stock logo
LFMDP
LifeMD
0.00
N/AN/AN/A
The Oncology Institute, Inc. stock logo
TOIIW
Oncology Institute
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aclarion, Inc. stock logo
ACONW
Aclarion
$77.88KN/AN/AN/AN/AN/A
DHACW
Digital Health Acquisition
N/AN/AN/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMDP
LifeMD
$193.33MN/AN/AN/AN/AN/A
The Oncology Institute, Inc. stock logo
TOIIW
Oncology Institute
$545.76MN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aclarion, Inc. stock logo
ACONW
Aclarion
N/AN/AN/AN/AN/AN/AN/AN/A8/28/2026 (Estimated)
DHACW
Digital Health Acquisition
N/AN/AN/AN/AN/AN/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMDP
LifeMD
N/AN/AN/AN/AN/AN/AN/AN/A8/6/2026 (Estimated)
The Oncology Institute, Inc. stock logo
TOIIW
Oncology Institute
N/AN/AN/AN/AN/AN/AN/AN/A8/11/2026 (Estimated)
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aclarion, Inc. stock logo
ACONW
Aclarion
N/AN/AN/AN/AN/A
DHACW
Digital Health Acquisition
N/AN/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMDP
LifeMD
$2.229.39%N/AN/AN/A
The Oncology Institute, Inc. stock logo
TOIIW
Oncology Institute
N/AN/AN/AN/AN/A

Latest TOIIW, ACONW, DHACW, and LFMDP Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/15/2026
LifeMD, Inc. stock logo
LFMDP
LifeMD
quarterly$0.55479.44%7/2/20267/3/20267/15/2026
(Data available from 1/1/2013 forward)

Institutional Ownership

CompanyInstitutional Ownership
Aclarion, Inc. stock logo
ACONW
Aclarion
N/A
DHACW
Digital Health Acquisition
N/A
LifeMD, Inc. stock logo
LFMDP
LifeMD
N/A
The Oncology Institute, Inc. stock logo
TOIIW
Oncology Institute
N/A

Insider Ownership

CompanyInsider Ownership
Aclarion, Inc. stock logo
ACONW
Aclarion
N/A
DHACW
Digital Health Acquisition
N/A
LifeMD, Inc. stock logo
LFMDP
LifeMD
N/A
The Oncology Institute, Inc. stock logo
TOIIW
Oncology Institute
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Aclarion, Inc. stock logo
ACONW
Aclarion
7N/AN/ANot Optionable
DHACW
Digital Health Acquisition
N/AN/AN/ANot Optionable
LifeMD, Inc. stock logo
LFMDP
LifeMD
230N/AN/ANot Optionable
The Oncology Institute, Inc. stock logo
TOIIW
Oncology Institute
660N/AN/ANot Optionable

Media Sentiment Over Time

Aclarion stock logo

Aclarion NASDAQ:ACONW

$0.02 +0.00 (+15.35%)
As of 02:47 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Digital Health Acquisition NASDAQ:DHACW

$0.03 -0.01 (-14.41%)
As of 06/30/2026

Digital Health Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on technology and healthcare focused businesses. Digital Health Acquisition Corp. was incorporated in 2021 and is based in Boca Raton, Florida.

LifeMD stock logo

LifeMD NASDAQ:LFMDP

$23.64 +0.15 (+0.62%)
As of 02:36 PM Eastern
This is a fair market value price provided by Massive. Learn more.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Oncology Institute stock logo

Oncology Institute NASDAQ:TOIIW

$0.04 0.00 (-6.37%)
As of 01:15 PM Eastern
This is a fair market value price provided by Massive. Learn more.

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.